Unpredictable In Vitro Killing Activity of Amphotericin B against Four <i>Candida auris</i> Clades
<i>Candida auris</i> is an emerging multiresistant yeast against which amphotericin B (AMB) is still the first therapeutic choice in certain clinical situations (i.e., meningitis, endophthalmitis, and urinary tract infections). As data about the in vitro killing activity of AMB against &...
Main Authors: | Zoltán Papp, Andrew M. Borman, Lajos Forgács, Renátó Kovács, Zoltán Tóth, Chiu Chun-Ju, Gábor Kardos, Béla Juhász, Judit Szilvássy, László Majoros |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/8/990 |
Similar Items
-
Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four <i>Candida auris</i> Clades in RPMI-1640 in the Absence and Presence of Human Serum
by: Renátó Kovács, et al.
Published: (2021-04-01) -
In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against <i>Candida auris</i>
by: Unai Caballero, et al.
Published: (2021-08-01) -
Antifungal Resistance in <i>Candida auris</i>: Molecular Determinants
by: María Guadalupe Frías-De-León, et al.
Published: (2020-09-01) -
Diagnostic Allele-Specific PCR for the Identification of <i>Candida auris</i> Clades
by: Hans Carolus, et al.
Published: (2021-09-01) -
Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against <i>Candida</i> Species
by: Zoltán Tóth, et al.
Published: (2020-08-01)